NDGA (Nordihydroguaiaretic acid) is an anti-oxidant 5-LO (5-lipoxygenase) inhibitor lignan found in Larrea tridentata. NDGA has been shown to synergistically enhanced the cytotoxicity of DOX, CPT and MTX on tumor cells. NDGA has been shown to inhibit the TGFβ R1 (TGF-β type 1 receptor) by repressing Smad2 phosphorylation. NDGA has displayed antimutagenic effects in a number of cell models through proposed action as a chain-breaking antioxidant. NDGA has also displayed antimicrobial activity. Additionally, this compound is an inhibitor of epidermal and hepatic CYP (cytochrome P450).
1. Lambert, J.D., et al. 2002. Toxicon. 40: 1701-1708. PMID: 12457882 2. Meyers, R.O., et al. 2009. Bioorg. Med. Chem. Lett. 19: 4752-4755. PMID: 19615898 3. Plaza, C., et al. 2009. In Vivo. 23: 959-967. PMID: 20023240 4. Chu, L.S., et al. 2010. Sheng Li Xue Bao. 62: 101-108. PMID: 20401443
Soluble in 100% ethanol, methanol, acetone, DMSO, DMF, ethanol (5% w/v), glycol, PEG, and slightly soluble in hot water. Insoluble in water.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Download SDS (MSDS)
Certificate of Analysis
Adobe Acrobat Reader is required to reliably view, print and comment on PDF documents
bvseo_sdk, java_sdk, bvseo-3.2.0
CLOUD, getContent, 118ms
bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of
ZhangZhang, X. et al. (PubMed 26311402) reported that combination of amniotic epithelial cells (AECs) with NDGA (Nordihydroguaiaretic acid; Dihydronorguaiaretic acid; nordihydroguaiaretate), an antioxidant and lipoxygenase inhibitor, promotes the survival of transplanted AECs in spinal cord-injured rats. -SCBT Publication Review
To place an order using RMB or to ship to mainland China, please visit www.scbio.cn